222 related articles for article (PubMed ID: 33770323)
1. Consolidating the Hyams grading system in esthesioneuroblastoma - an individual participant data meta-analysis.
Vuong HG; Ngo TNM; Dunn IF
J Neurooncol; 2021 May; 153(1):15-22. PubMed ID: 33770323
[TBL] [Abstract][Full Text] [Related]
2. Esthesioneuroblastoma and sinonasal undifferentiated carcinoma: impact of histological grading and clinical staging on survival and prognosis.
Miyamoto RC; Gleich LL; Biddinger PW; Gluckman JL
Laryngoscope; 2000 Aug; 110(8):1262-5. PubMed ID: 10942123
[TBL] [Abstract][Full Text] [Related]
3. [New system combining Hyams grading system and modified Kadish stage to evaluate the progress of esthesioneuroblastoma].
Lai YY; Lin TJ; Jiang LJ; Deng J; Zuo KJ; Zhang Y; Shi JB
Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2019 Jul; 33(7):599-602. PubMed ID: 31327194
[No Abstract] [Full Text] [Related]
4. Prognostic utility of Hyams histological grading and Kadish-Morita staging systems for esthesioneuroblastoma outcomes.
Bell D; Saade R; Roberts D; Ow TJ; Kupferman M; DeMonte F; Hanna EY
Head Neck Pathol; 2015 Mar; 9(1):51-9. PubMed ID: 24806334
[TBL] [Abstract][Full Text] [Related]
5. [A retrospective study about 11 cases of Esthesioneuroblastomas treated in Hospital Santa Creu i Sant Pau between 2000 and 2008 and literature review].
Muñoz F; Tresserras P; Montserrat JR; Sancho FJ; Bartumeus F
Neurocirugia (Astur); 2011 Oct; 22(5):401-17; discussion 417-8. PubMed ID: 22031159
[TBL] [Abstract][Full Text] [Related]
6. Microvessel density and Ki-67 labeling index in esthesioneuroblastoma: is there a prognostic role?
Singh L; Ranjan R; Madan R; Arava SK; Deepak RK; Singh MK
Ann Diagn Pathol; 2015 Dec; 19(6):391-6. PubMed ID: 26343569
[TBL] [Abstract][Full Text] [Related]
7. Low- and high-grade esthesioneuroblastomas display a distinct natural history and outcome.
Malouf GG; Casiraghi O; Deutsch E; Guigay J; Temam S; Bourhis J
Eur J Cancer; 2013 Apr; 49(6):1324-34. PubMed ID: 23312882
[TBL] [Abstract][Full Text] [Related]
8. Hyams grading as a predictor of metastasis and overall survival in esthesioneuroblastoma: a meta-analysis.
Goshtasbi K; Abiri A; Abouzari M; Sahyouni R; Wang BY; Tajudeen BA; Hsu FPK; Cadena G; Kuan EC
Int Forum Allergy Rhinol; 2019 Sep; 9(9):1054-1062. PubMed ID: 31251848
[TBL] [Abstract][Full Text] [Related]
9. Esthesioneuroblastoma: updating histologic grading as it relates to prognosis.
Gallagher KK; Spector ME; Pepper JP; McKean EL; Marentette LJ; McHugh JB
Ann Otol Rhinol Laryngol; 2014 May; 123(5):353-8. PubMed ID: 24668054
[TBL] [Abstract][Full Text] [Related]
10. Immunohistochemical Profiling and Staging in Esthesioneuroblastoma: A Single-Center Cohort Study and Systematic Review.
Henson JC; Cutler CC; Cole KL; Lucke-Wold B; Khan M; Alt JA; Karsy M
World Neurosurg; 2023 Feb; 170():e652-e665. PubMed ID: 36435382
[TBL] [Abstract][Full Text] [Related]
11. Esthesioneuroblastoma: a meta-analysis and review.
Dulguerov P; Allal AS; Calcaterra TC
Lancet Oncol; 2001 Nov; 2(11):683-90. PubMed ID: 11902539
[TBL] [Abstract][Full Text] [Related]
12. [Primary experience and discussion on the treatment of esthesioneuroblastoma].
Jiang LJ; Lin TJ; Huang ZQ; Zuo KJ; Zhang Y; Shi JB; Lai YY
Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2021 Jul; 56(7):719-723. PubMed ID: 34344098
[No Abstract] [Full Text] [Related]
13. Orbital invasion by Esthesioneuroblastoma: a comparative case series and review of literature.
Wu K; Avila SA; Bhuyan R; Matloob A; Del Signore AG; Hadjipanayis C; Chelnis J
Orbit; 2022 Feb; 41(1):1-14. PubMed ID: 33317383
[TBL] [Abstract][Full Text] [Related]
14. Multicenter Survival Analysis and Application of an Olfactory Neuroblastoma Staging Modification Incorporating Hyams Grade.
Choby G; Geltzeiler M; Almeida JP; Champagne PO; Chan E; Ciporen J; Chaskes MB; Fernandez-Miranda J; Gardner P; Hwang P; Ji KSY; Kalyvas A; Kong KA; McMillan R; Nayak J; O'Byrne J; Patel C; Patel Z; Peris Celda M; Pinheiro-Neto C; Sanusi O; Snyderman C; Thorp BD; Van Gompel JJ; Young SC; Zenonos G; Zwagerman NT; Wang EW
JAMA Otolaryngol Head Neck Surg; 2023 Sep; 149(9):837-844. PubMed ID: 37535372
[TBL] [Abstract][Full Text] [Related]
15. Long-term oncologic outcomes in esthesioneuroblastoma: An institutional experience of 143 patients.
McMillan RA; Van Gompel JJ; Link MJ; Moore EJ; Price DL; Stokken JK; Van Abel KM; O'Byrne J; Giannini C; Chintakuntlawar A; Pinheiro Neto CD; Peris Celda M; Foote R; Choby G
Int Forum Allergy Rhinol; 2022 Dec; 12(12):1457-1467. PubMed ID: 35385606
[TBL] [Abstract][Full Text] [Related]
16. [Long-term experiences in the therapy of esthesioneuroblastoma].
Koch M; Constantinidis J; Dimmler A; Strauss C; Iro H
Laryngorhinootologie; 2006 Oct; 85(10):723-30. PubMed ID: 16673299
[TBL] [Abstract][Full Text] [Related]
17. Long-term outcome of esthesioneuroblastoma: hyams grade predicts patient survival.
Van Gompel JJ; Giannini C; Olsen KD; Moore E; Piccirilli M; Foote RL; Buckner JC; Link MJ
J Neurol Surg B Skull Base; 2012 Oct; 73(5):331-6. PubMed ID: 24083125
[TBL] [Abstract][Full Text] [Related]
18. Comparing Kadish and Modified Dulguerov Staging Systems for Olfactory Neuroblastoma: An Individual Participant Data Meta-analysis.
Arnold MA; Farnoosh S; Gore MR
Otolaryngol Head Neck Surg; 2020 Sep; 163(3):418-427. PubMed ID: 32286935
[TBL] [Abstract][Full Text] [Related]
19. The clinicopathological spectrum of olfactory neuroblastoma and sinonasal neuroendocrine neoplasms: Refinements in diagnostic criteria and impact of multimodal treatments on survival.
Turri-Zanoni M; Maragliano R; Battaglia P; Giovannardi M; Antognoni P; Lombardi D; Morassi ML; Pasquini E; Tarchini P; Asioli S; Foschini MP; Sessa F; Nicolai P; Castelnuovo P; La Rosa S
Oral Oncol; 2017 Nov; 74():21-29. PubMed ID: 29103747
[TBL] [Abstract][Full Text] [Related]
20. Clincopathological analysis of olfactory neuroblastoma.
Fukushima S; Sugita Y; Niino D; Mihashi H; Ohshima K
Brain Tumor Pathol; 2012 Oct; 29(4):207-15. PubMed ID: 22331316
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
